01—History
Stockholders' Equity History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $8.65B
2 older moves run past ±150% (largest +452.3%); point at, tap or drag across the bars to read one.
02—Ledger
Stockholders' Equity, period by period
03—Questions
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is Moderna, Inc.'s current stockholders' equity?
Moderna, Inc. (MRNA) annual stockholders' equity for 2025 was $8.65B, a 20.65% decline from 2024. Moderna, Inc. stockholders' equity for the quarter ending March 31, 2026 was $7.41B.
What was Moderna, Inc.'s stockholders' equity in 2024?
Moderna, Inc. annual stockholders' equity for 2024 was $10.90B, a 21.32% decline from 2023.
What was Moderna, Inc.'s stockholders' equity in 2023?
Moderna, Inc. annual stockholders' equity for 2023 was $13.85B, a 27.55% decline from 2022.
What is Moderna, Inc.'s 5-year stockholders' equity CAGR?
Moderna, Inc. stockholders' equity grew at a compound annual growth rate (CAGR) of 27.56% from FY2020 to FY2025, going from $2.56B to $8.65B over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)